18.85
Schlusskurs vom Vortag:
$18.85
Offen:
$18.93
24-Stunden-Volumen:
226.70K
Relative Volume:
0.50
Marktkapitalisierung:
$531.59M
Einnahmen:
$242.12M
Nettoeinkommen (Verlust:
$-351.72M
KGV:
-1.4184
EPS:
-13.29
Netto-Cashflow:
$24.82M
1W Leistung:
+0.16%
1M Leistung:
+109.44%
6M Leistung:
+43.13%
1J Leistung:
+11.47%
Zimvie Inc Stock (ZIMV) Company Profile
Firmenname
Zimvie Inc
Sektor
Branche
Telefon
800-342-5454
Adresse
4555 RIVERSIDE DRIVE, PALM BEACH GARDEN
Vergleichen Sie ZIMV mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ZIMV
Zimvie Inc
|
18.85 | 531.02M | 242.12M | -351.72M | 24.82M | -13.29 |
![]()
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
![]()
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Zimvie Inc Stock (ZIMV) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-31 | Herabstufung | B. Riley Securities | Buy → Neutral |
2025-07-22 | Hochstufung | Barclays | Underweight → Equal Weight |
2025-04-10 | Eingeleitet | B. Riley Securities | Buy |
2025-03-13 | Herabstufung | Needham | Buy → Hold |
2024-05-16 | Hochstufung | Needham | Hold → Buy |
2023-11-16 | Eingeleitet | Needham | Hold |
2022-12-21 | Eingeleitet | Barclays | Underweight |
2022-06-17 | Eingeleitet | JP Morgan | Neutral |
2022-03-18 | Eingeleitet | Guggenheim | Neutral |
Alle ansehen
Zimvie Inc Aktie (ZIMV) Neueste Nachrichten
Can ZimVie Inc. deliver consistent dividendsBreakout to Riches Picks - classian.co.kr
ZimVie to be acquired by Archimed for $19.00 per share in cash - MSN
Using RSI to spot recovery in ZimVie Inc.Minimal Risk Growth Investment Opportunity Analysis - Newser
Will ZimVie Inc. see short term momentumHigh Probability Trade Plan with Indicators - Newser
Can swing trading help recover from ZimVie Inc. lossesFree Verified Signal From Chart Patterns - Newser
Is ZimVie Inc. stock ready for a breakoutTrend Reversal Watch with Entry Signals - Newser
What data driven models say about ZimVie Inc.’s futureFast Return Equity Forecast With Logic - Newser
ZimVie Doubles — And Then Some — On Its Second Takeover Deal - MSN
ZimVie (ZIMV) Q2 EPS Doubles to $0.26 - AOL.com
What earnings revisions data tells us about ZimVie Inc.Long Term Stock Planner with Safety Checks - Newser
Reversal indicators forming on ZimVie Inc. stockROI Focused Watchlist with Trade Confidence - Newser
What makes ZimVie Inc. stock price move sharplyFree Stock Market Forecast Reports - Jammu Links News
What analysts say about ZimVie Inc. stockMaximize returns with strategic trading plans - Jammu Links News
Is ZimVie Inc. stock overvalued or undervaluedUnlock expert insights for smarter investing - Jammu Links News
Is ZimVie Inc. a growth stock or a value stockCapitalize on emerging market trends - Jammu Links News
What are ZimVie Inc. company’s key revenue driversInvest smarter with daily stock recommendations - Jammu Links News
What catalysts could drive ZimVie Inc. stock higher in 2025Get timely alerts on top-performing stocks - Jammu Links News
What drives ZimVie Inc. stock priceInvest smarter with comprehensive market analysis - Jammu Links News
What is ZimVie Inc. company’s growth strategyPhenomenal returns - Jammu Links News
When is ZimVie Inc. stock expected to show significant growthFree Trading Strategy Suggestions - Jammu Links News
What are analysts’ price targets for ZimVie Inc. in the next 12 monthsHigh-yield growth strategies - Jammu Links News
How does ZimVie Inc. generate profit in a changing economyMarket Forecast Signals For Fast Growth - Jammu Links News
What is the risk reward ratio of investing in ZimVie Inc. stockMarket Forecast Insights For 2025 - Jammu Links News
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE) and ZimVie Inc (ZIMV) - The Globe and Mail
Does ZimVie Inc. stock perform well during market downturnsBreakout Stocks Watchlist That Work - jammulinksnews.com
ZimVie Tops Estimates But Preps For ARCHIMED Buyout - Finimize
B.Riley downgrades ZimVie stock rating to Neutral on acquisition news - Investing.com Canada
Real time alert setup for ZimVie Inc. performanceFree Growth Focused Entry Plan Suggestions - Newser
ZimVie Inc. Reports Q2 2025 Results Amid Acquisition - TipRanks
ZimVie earnings beat by $0.03, revenue topped estimates - Investing.com Canada
ZimVie Reports Second Quarter 2025 Financial Results - The Manila Times
Dental Implant Leader ZimVie Agrees to $19 Per Share Buyout as Q2 Shows Margin Improvement - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: iTeos Therapeutics, Inc. (NasdaqITOS), ZimVie Inc. (NasdaqZIMV), PharmChem, Inc. (OTCPCHM), NV5 Global, Inc. (NasdaqNVEE) - Morningstar
ZimVie Inc. Forms Bullish Flag — Upside AheadLow Risk Equity Screener With Results Shared - metal.it
ZimVie’s Discounted Stock Draws Buyout Bids And Investor Caution - Finimize
ZimVie Inc. Sees Relief Buying After Extended DropReversal Alert Based on RSI Indicator Confirmed - metal.it
Published on: 2025-07-29 00:19:04 - metal.it
ZimVie Inc expected to post earnings of 21 cents a shareEarnings Preview - TradingView
What institutions are buying ZimVie Inc. stock nowFast Gaining Stock Screener Reports Released - beatles.ru
What are the technical indicators suggesting about ZimVie Inc.Free Stock Market Forecast Reports - Jammu Links News
What are the latest earnings results for ZimVie Inc.Free Trend-Following Techniques - jammulinksnews.com
What institutional investors are buying ZimVie Inc. stockGain access to exclusive stock analysis - Jammu Links News
Finanzdaten der Zimvie Inc-Aktie (ZIMV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Zimvie Inc-Aktie (ZIMV) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Kidwell Heather | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
8,063 |
0 |
85,880 |
Kanaglekar Indraneel | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
10,966 |
0 |
64,830 |
Jamali Vafa | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
48,379 |
0 |
408,636 |
Heppenstall Richard | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
16,127 |
0 |
130,373 |
Jamali Vafa | See remarks below. |
Apr 01 '25 |
Option Exercise |
0.00 |
21,331 |
0 |
369,590 |
Schneider Sandra | Chief Accounting Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,590 |
0 |
33,252 |
Schneider Sandra | Chief Accounting Officer |
Mar 07 '25 |
Option Exercise |
0.00 |
6,542 |
0 |
31,415 |
Heppenstall Richard | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
6,938 |
0 |
115,936 |
Heppenstall Richard | See remarks below. |
Mar 07 '25 |
Option Exercise |
0.00 |
24,650 |
0 |
115,337 |
Kanaglekar Indraneel | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
4,163 |
0 |
54,878 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):